Arcadia Biosciences Inc (RKDA) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 31.18%1.44 | 1.10 | 0.90 | 1.30 | 1.46 |
| Cost Of Revenue | 16.00%0.81 | 0.70 | 0.71 | 0.88 | 0.82 |
4.41%1.13 | 1.18 | 1.57 | - | 2.12 | |
| Selling, General, and Administrative | 4.41%1.13 | 1.18 | 1.57 | - | 2.12 |
| Research and Development | - | - | - | - | 0.01 |
| Costs And Expenses | 3.19%1.94 | 1.88 | 2.28 | 2.45 | 1.96 |
| Operating Income/Loss | 36.33%-0.50 | -0.78 | -1.38 | -1.15 | -0.50 |
| Net Interest Income/Expense | 60.00%0.00 | 0.01 | -0.00 | 0.01 | 0.01 |
42.90%-6.27 | -4.39 | -1.34 | 0.86 | -4.46 | |
| Attributable To Parent | 42.90%-6.27 | -4.39 | -1.34 | 0.86 | -4.46 |
| Basic Average Shares | 43.67%2.99 | 2.08 | - | 1.37 | 1.37 |
| Diluted Average Shares | 43.67%2.99 | 2.08 | - | 1.37 | 1.37 |
| Basic Earnings Per Share | 0.95%-2.09 | -2.11 | - | 0.63 | -3.26 |
| Diluted Earnings Per Share | 0.95%-2.09 | -2.11 | - | 0.62 | -3.26 |